Table 1 (A) Overview of the analysed patient microarray data sets. (B) Number of signature genes represented in the microarray data set (number of gene identifiers on the arrays are given between parentheses)
(A) Data set | Cancer site | No. of patients | Source | Â |
|---|---|---|---|---|
Miller | Breast | 251 | GEO accession GSE3494: http://www.ncbi.nlm.nih.gov/projects/geo/ | Â |
Wang | Breast | 286 | GEO accession GSE2034: http://www.ncbi.nlm.nih.gov/projects/geo/ | Â |
Van de Vijver | Breast | 295 | Â | |
Zhao | Renal | 177 | Â | |
Beer | Lung | 86 | http://dot.ped.med.umich.edu:2000/ourimage/pub/Lung/index.html | Â |
(B) Data set | Signature 1 | Signature 2 | Wound signature | IGS signature |
Miller | 455 (1120) | 104 (228) | 415 (1030) | 176 (516) |
Wang | 350 (667) | 87 (158) | 346 (614) | 131 (270) |
Van de Vijver | 192 (242) | 51 (59) | 171 (195) | 67 (87) |
Zhao | 257 (415) | 47 (82) | 280 (446) | 83 (132) |
Beer | 192 (224) | 45 (51) | 171 (195) | 63 (76) |
